Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Perrotte

Showing results (1-10 of 245) with videos related to

Pageof 25
Sort By:
World Journal of Urology|January 25, 2005
The role of bisphosphonates in hormone-refractory prostate cancerFred Saad, Pierre Karakiewicz, Paul Perrotte
Nature Reviews. Urology|June 11, 2010
Pazopanib trial data cannot support first-line useClaudio Jeldres, Maxine Sun, Paul Perrotte, et al.
Nature Reviews. Urology|May 12, 2010
Treatment of metastatic renal cell carcinomaMaxine Sun, Giovanni Lughezzani, Paul Perrotte, et al.
European Urology|March 21, 2014
Words of wisdom: Re: Pazopanib versus sunitinib in metastatic renal-cell carcinomaMaxine Sun, Quoc-Dien Trinh, Paul Perrotte, et al.
European Urology|February 6, 2007
Rebuttal from authors re: Edward M. Messing. Node positive renal cell cancer. Who can be helped? Eur Urol 2007;51:1477-8Pierre Karakiewicz, Paul Perrotte, Quoc-Dien Trinh, et al.
The Canadian Journal of Urology|January 13, 2006
An epidural abscess following transrectal ultrasound-guided biopsies of the prostateVincent Fradet, Michael McCormack, Paul Perrotte, et al.
The Canadian Journal of Urology|July 16, 2005
Bone health in men with prostate cancer: diagnostic and therapeutic considerationsFred Saad, Paul Perrotte, François Bénard, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2008
Management of hepatic granulomatous tuberculosis complicating intravesical BCG for superficial bladder cancerVincent Fradet, Christiane Gaudreau, Paul Perrotte, et al.
European Urology|January 21, 2006
Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancerRobert Svatek, Pierre I Karakiewicz, Michael Shulman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Population-based external validation of a competing-risks nomogram for patients with localized renal cell carcinomaGiovanni Lughezzani, Maxine Sun, Lars Budäus, et al.
Pageof 25

Showing results (1-10 of 245) with videos related to

Sort By:
Pageof 25
World Journal of Urology|January 25, 2005
The role of bisphosphonates in hormone-refractory prostate cancerFred Saad, Pierre Karakiewicz, Paul Perrotte
Nature Reviews. Urology|June 11, 2010
Pazopanib trial data cannot support first-line useClaudio Jeldres, Maxine Sun, Paul Perrotte, et al.
Nature Reviews. Urology|May 12, 2010
Treatment of metastatic renal cell carcinomaMaxine Sun, Giovanni Lughezzani, Paul Perrotte, et al.
European Urology|March 21, 2014
Words of wisdom: Re: Pazopanib versus sunitinib in metastatic renal-cell carcinomaMaxine Sun, Quoc-Dien Trinh, Paul Perrotte, et al.
European Urology|February 6, 2007
Rebuttal from authors re: Edward M. Messing. Node positive renal cell cancer. Who can be helped? Eur Urol 2007;51:1477-8Pierre Karakiewicz, Paul Perrotte, Quoc-Dien Trinh, et al.
The Canadian Journal of Urology|January 13, 2006
An epidural abscess following transrectal ultrasound-guided biopsies of the prostateVincent Fradet, Michael McCormack, Paul Perrotte, et al.
The Canadian Journal of Urology|July 16, 2005
Bone health in men with prostate cancer: diagnostic and therapeutic considerationsFred Saad, Paul Perrotte, François Bénard, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2008
Management of hepatic granulomatous tuberculosis complicating intravesical BCG for superficial bladder cancerVincent Fradet, Christiane Gaudreau, Paul Perrotte, et al.
European Urology|January 21, 2006
Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancerRobert Svatek, Pierre I Karakiewicz, Michael Shulman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Population-based external validation of a competing-risks nomogram for patients with localized renal cell carcinomaGiovanni Lughezzani, Maxine Sun, Lars Budäus, et al.
Pageof 25